Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2018

Jan 8, 2018

30150_dirs_2018-01-08_4f177775-5210-4f50-a163-dd28a434d50f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2018-01-04

Reporting Person: Schaeffer Orlov S Nicole (SVP, HR & Corp. Svcs.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-01-04 Common Stock A 10669 Acquired 10669 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-01-04 Stock Option $30.46 A 55400 Acquired 2028-01-04 Common Stock (55400) Direct

Footnotes

F1: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2: Each Restricted Stock Unit was received as a grant on January 4, 2018, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3: Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.